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Edited by Gianni CesareniAbstract The very C-terminus of c-Src is a ligand for PDZ do-
mains. In a screen for PDZ domains that interact with c-Src, we
identiﬁed one of the PDZ domains of the Ligand-of-Numb pro-
tein X1 (LNX1), a multiple PDZ domain scaﬀold and RING
type E3 ubiquitin ligase. We demonstrate that the interaction
of c-Src with LNX1 depends on the C-terminal PDZ ligand of
c-Src. Furthermore, we show that c-Src phosphorylates LNX1.
Moreover, c-Src itself is ubiquitinated by LNX1, suggesting an
interdependent regulation of c-Src and LNX1.
 2007 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Ubiquitination1. Introduction
c-Src is a tightly regulated non-receptor tyrosine kinase.
Overexpression or increased kinase activity of c-Src is fre-
quently detected in human malignancies. c-Src is important
for many cellular processes such as receptor-mediated signal-
ing, cell adhesion, motility, cell proliferation and survival [1,2].
c-Src is composed of a C-terminal tail containing a negative-
regulatory tyrosine residue (Tyr529), four Src homology (SH)
domains and a unique amino-terminal domain (Fig. 1A) [1,2].
The SH1 tyrosine kinase domain contains the autophosphory-
lation site (Tyr418). The SH2 and SH3 protein–protein inter-
action domains interact with phosphotyrosine-containing
motifs and proline-rich sequences, respectively. A short SH4
domain including a myristoyl group targets c-Src to mem-
branes. Negative regulation of c-Src involves an intramolecu-
lar interaction between the SH2 domain and phosphorylated
Tyr529, and of the SH3 domain with the SH1–SH2 linker re-
gion. This closed conformation is reversed by protein tyrosine
phosphatases (PTP) and the interaction of the c-Src SH2 and
SH3 domains with other proteins, which disrupt the inhibitoryAbbreviations: LNX1, Ligand-of-Numb protein X1; PDZ, PSD-95,
postsynaptic density 95; Dlg, disc large; ZO-1, zonula occludens-1; SH,
Src homology; PTB, phosphotyrosine binding; GST, glutathione-S-
transferase
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activated by autophosphorylation of Tyr418.
Recently, we described the very C-terminus of c-Src, GENL
(Gly-Glu-Asn-Leu), as a ligand for the PDZ domain protein
AF-6 [3]. PDZ domain proteins are multidomain proteins
and function as scaﬀolds to organize cell adhesion complexes,
to cluster transmembrane proteins, and serve as points of inte-
gration or divergence in signaling cascades [4]. In many cases
PDZ proteins contribute to the maintenance of a non-prolifer-
ating state [5].
Ligand-of-Numb protein X1 (LNX1) was ﬁrst identiﬁed as
an interaction partner for the cell fate determinant and endo-
cytic protein Numb [6]. LNX1 contains at its N-terminus a
RING domain, which speciﬁes LNX1 as an E3 ubiquitin ligase
[7], followed by an amino acid motif NPAY for interaction
with phosphotyrosine-binding (PTB) domains, and four PDZ
domains, which mediate protein–protein interactions
(Fig. 1A). LNX1 has been described as E3 ubiquitin ligase
and endocytic scaﬀold, e.g. for Numb [8,9]. A shorter alterna-
tively spliced isoform, p70LNX1, lacking the RING domain
has been described in brain and kidney [6,10] and acts as an
endocytic scaﬀold.
To further study the role of PDZ ligand-mediated interac-
tions of c-Src, we performed a screen for PDZ domains that
interact with c-Src. One candidate we identiﬁed was the
PDZ3 domain of LNX1, a RING type E3 ubiquitin ligase.
Here, we present biochemical and biological data on the inter-
action of c-Src with LNX1 and show their mutual regulation.2. Materials and methods
2.1. Antibodies
Antibodies used: anti-FLAG (Sigma); anti-Src GD11, anti-phospho-
tyrosine (4G10) (Upstate); anti-c-Src (Src2), anti-myc (9E10), anti-
tubulin (Santa Cruz); anti-Src (32G6) (Cell Signaling Technology).
Polyclonal LNX1/55 and LNX1/56 aﬃnity puriﬁed peptide antibodies
were generated against aa 134–148 and aa 671–685, respectively (Euro-
gentec).
2.2. Plasmids
Human LNX1 was obtained as cDNA clone (RZPD, Germany; IR-
ATp970C0541D; BC022983). The coding sequence was subcloned into
pcDNA3 by PCR and fusing the FLAG-tag sequence 5 0 to the coding
sequence. FLAG-LNX1DPDZ, FLAG-LNX1-NT and FLAG-LNX1-
CT constructs were generated by PCR mutagenesis. Src expression
constructs were described previously [3]. The myc-Ubiquitin plasmid
was a gift from Dr. Y. Yarden (Rehovot, Israel).
2.3. Cell culture and transfection
Cell culture and transient transfection were described elsewhere [3].ation of European Biochemical Societies.
Fig. 1. c-Src interacts with LNX1 PDZ3. (A) Schematic representation of LNX1 and c-Src. Regions encoded by the diﬀerent constructs are shown.
(B) PDZ arrays were incubated with HEK 293 cell lysates overexpressing c-Src. Bound c-Src was detected by blotting with anti-Src.
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TranSignal PDZ domain arrays were obtained from Panomics
(Redwood City, USA) and incubated according to the manual with ly-
sates of HEK 293 cells overexpressing c-Src or control protein. Bound
c-Src was detected by blotting with anti-Src antibody.
2.5. Immunoprecipitations, immunoblots and immunoﬂuorescence
microscopy
Experiments were performed as described previously [3].3. Results
3.1. c-Src interacts with the PDZ3 domain of LNX1
Recently, we described the C-terminal sequence GENL of c-
Src as a PDZ ligand that binds to the PDZ domain of the cell
junction protein AF-6 [3]. We assumed the existence of further
PDZ domains that may interact with the C-terminal sequence of
c-Src. To identify such PDZ domains, we screened PDZ domain
arrays, which included a total of 123 diﬀerent human PDZ do-
mains. The membranes were incubated with lysates of human
embryonic kidney (HEK) 293 cells overexpressing c-Src
(Fig. 1B) or a control protein (data not shown). Bound protein
was detected by blotting with a Src-speciﬁc antibody. We found
that c-Src interacted with the PDZ3 domain of LNX1, the only
of four PDZ domain of LNX1 present on the arrays.3.2. PDZ-dependent interaction and co-localization of c-Src and
LNX1
Next, we analyzed whether c-Src and full-length LNX1 can
interact. HEK 293 cells were transiently transfected with plas-
mids encoding wild-type c-Src (Src-L) and FLAG-LNX1. Src-
L coprecipitated with FLAG-LNX1, and FLAG-LNX1 copre-
cipitated with Src-L (Fig. 2A and B). A mutant of c-Src (Src-
A) where the C-terminal hydrophobic amino acid Leu is re-
placed with Ala leading to impaired binding to PDZ domains
[5] showed reduced coprecipitation with FLAG-LNX1
(Fig. 2A), and vice versa FLAG-LNX1 with Src-A (Fig. 2B).
Thus, c-Src binds to LNX1 in a PDZ domain-dependent man-
ner.
We next investigated the co-localization of c-Src and LNX1
upon coexpression in HeLa cells by confocal microscopy. Src-
L was distributed throughout the cytoplasm, near the plasma
membrane and at sites of cell–cell contacts (Fig. 2C, red).
FLAG-LNX1 was diﬀusively distributed throughout the cell,
including in the nucleus, and regions near the plasma mem-
brane (Fig. 2C, green). We also observed localization of
FLAG-LNX1 to microtubuli-like structures. Src-L and
FLAG-LNX1 partially co-localized at membrane regions
and cell-cell contacts (Fig. 2C, upper panel, arrow) and in
membrane ruﬄes (Fig. 2C, lower panel). Hence, the co-locali-
zation of c-Src and LNX1 in speciﬁc subcellular compartments
Fig. 2. Interaction of c-Src and LNX1. (A,B) Plasmids encoding FLAG-LNX1, Src-L, Src-A or empty vector () were transfected into HEK 293
cells as indicated. Cell lysates were immunoprecipitated (IP) with anti-FLAG (A) or anti-Src (B) and immunoblotted (IB) with anti-Src, or anti-
FLAG. Equal expression of Src constructs was conﬁrmed by blotting cell lysates with anti-Src. (C) Co-localization of c-Src and LNX1. HeLa cells
were transfected with FLAG-LNX1 and Src-L, ﬁxed and immunostained with rabbit anti-FLAG (green) and mouse anti-Src GD11 (red) antibodies.
Single confocal sections in green and red channel and overlay thereof are shown. LNX1 and Src-L co-localize at cell–cell contacts (arrow) in punctae
in the cytoplasm and in peripheral membrane ruﬄes (magniﬁcation of squared areas); bar is 20 lm. (D) Coprecipitation of endogenous c-Src and
LNX1 from mouse brain extracts. Proteins were precipitated from extracts and blotted with the indicated antibodies.
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and LNX1.
To test whether c-Src and LNX1 also interact in vivo, we
immunoprecipitated LNX1 from mouse brain lysate
(Fig. 2D). LNX1 cannot be detected in whole brain lysate
but is detected following immunoprecipitation. c-Src speciﬁ-
cally coprecipitated with LNX1, indicating that the complex
exists in vivo.
3.3. Mapping the interaction of c-Src and LNX1
We next examined the interaction sites for c-Src on LNX1.
We coexpressed Src-L with FLAG-tagged full-length LNX1,
LNX1DPDZ3, LNX1-NT or LNX1-CT (Fig. 1A). As before,
Src-L coprecipitated with FLAG-LNX1, and to a similar ex-
tend with FLAG-LNX1-CT (Fig. 3). Src-L showed a reduced
binding to FLAG-LNX1DPDZ3 and no binding to FLAG-LNX1-NT. In pulldown assays, we analyzed the interaction
of GST-fusion proteins of individual PDZ domains with
in vitro translated Src-L and SrcCT-L (C-terminus of c-Src
harboring the PDZ ligand). For both proteins, we conﬁrmed
the interaction with GST-PDZ3 and observed a stronger inter-
action with GST-PDZ1, but no signiﬁcant interaction with
GST-PDZ2 and GST-PDZ4 (data not shown).
These data demonstrate that c-Src interacts with PDZ1 and
PDZ3 domains of LNX1. Residual binding of c-Src to LNX1
indicates a contribution of PDZ domain-independent interac-
tion.
3.4. Src-mediated phosphorylation of LNX1
The interaction between c-Src and LNX1 raised the question
whether LNX1 was a substrate for Src kinase. Upon coexpres-
sion of FLAG-LNX1 and Src-L in HEK 293 cells, we observed
Fig. 4. Src-mediated phosphorylation of LNX1. HEK 293 cells were
transfected as indicated. (A) Cells were treated with or without
pervanadate (PV) for 15 min, and FLAG-LNX was precipitated with
anti-FLAG and blotted with anti-phospho-tyrosine. Equal loading
and expression was controlled using anti-FLAG and anti-Src anti-
bodies. (B) Cells were lysed in presence of 0.5% SDS and 0.5% DOC
and analyzed as under (A).
Fig. 3. Mapping the interaction of Src and LNX1. HEK 293 cells were
transfected as indicated. LNX1 was precipitated with anti-FLAG and
blotted with anti-Src. IB with anti-FLAG and anti-Src antibodies were
used as control.
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by treating cells with pervanadate, a potent PTP inhibitor
(Fig. 4A). For further investigation, we expressed the constitu-
tively activated SrcCT-L protein together with FLAG-LNX1-
NT or FLAG-LNX1-CT. We detected Src-dependent phos-
phorylation of LNX1-NT and no signiﬁcant phosphorylation
of LNX1-CT (Fig. 4B).
3.5. LNX1-dependent ubiquitination of activated Src
We also asked whether the Src kinase activity plays a role for
the c-Src/LNX1 interaction. We coexpressed SrcCT proteins
with FLAG-LNX1 in HEK 293 cells. SrcCT-L bound very
strongly to FLAG-LNX1, whereas the mutant SrcCT-A
showed a markedly reduced interaction (Fig. 5A). The corre-
sponding kinase-defective proteins SrcCT/kd-L and SrcCT/
kd-A showed the same eﬀect (Fig. 5A), indicating that the
Src kinase activity does not aﬀect the Src/LNX1 interaction.
Interestingly, we also observed a Src kinase activity-dependent
mobility shift of coprecipitated constitutively activated SrcCT-
L, but not of kinase-defective SrcCT/kd-L (Fig. 5A). There-
fore, we analyzed the interaction of SrcCT-L with FLAG-
LNX1DPDZ deletion mutants (Fig. 1A) and the mobility shift
of coprecipitated SrcCT-L. SrcCT-L binding to LNX1 and
mobility shift of coprecipitated SrcCT-L increased with grad-
ual C-terminal deletion of PDZ domains (Fig. 5B). In contrast,
SrcCT-L only weakly bound to LNX1-NT and coprecipitated
SrcCT-L was not shifted, indicating that PDZ1 is necessary for
both, suﬃcient interaction and modiﬁcation of SrcCT. Fur-
thermore, shifted SrcCT proteins coprecipitated by LNX1
are phosphorylated at Tyr416 (data not shown).
This mobility shift depends on Src kinase activity (Fig 5A)
and is characteristic of protein ubiquitination. We tested this
by cotransfection of SrcCT-L and myc-Ubiquitin into HEK
293 cells with FLAG-LNX1 or FLAG-LNX1DPDZ234, the
LNX1 mutant with increased ubiquitin ligase activity. We
inhibited proteasomal degradation and protein synthesis by
treating cells with MG132 and cycloheximide, and analyzed
SrcCT-L proteins. Inhibitor treatment resulted in a smear of
SrcCT cotransfected with LNX1, which was increased using
LNX1DPDZ234 (Fig. 5C). This suggested LNX1-mediatedubiquitination of SrcCT. To further prove this, we precipitated
SrcCT-L and immunoblotted with anti-myc antibody to detect
ubiquitinated SrcCT-L proteins. SrcCT-L was ubiquitinated
and ubiquitination increased when LNX1 or LNX1DPDZ234
was coexpressed (Fig. 5D). Consistently, we observed de-
creased protein levels of constitutively activated full length
SrcY527F when cotransfected with FLAG-LNX1 and myc-
Ubiquitin (Fig. 5E). These data suggest that activated Src is
ubiquitinated by LNX1 and targeted for degradation.4. Discussion
The C-terminus of c-Src, GENL, is a ligand for PDZ do-
mains and binds to the PDZ domain of AF-6 [3]. Most PDZ
ligands show promiscuity and bind to diﬀerent PDZ domains
[4]. Using PDZ domain arrays, we searched for additional
PDZ domains to interact with the c-Src ligand and identiﬁed
the PDZ3 domain of LNX1. We also observed a binding of
Src-L and SrcCT-L to GST-PDZ1 (data not shown). We dem-
onstrated here that c-Src and LNX1 interacted within cells and
Fig. 5. LNX1-dependent ubiquitination of activated Src. (A–E) HEK 293 cells were transfected and lysates analyzed as indicated. (C) Cells were
treated with or without 50 lMMG132 and 20 lg/ml cycloheximide (CHX) for 3 h prior to lysis. (F) Model of interaction between c-Src and LNX1.
For details, see text.
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ing a defective PDZ ligand, or the LNX1DPDZ3 mutant, we
showed that this interaction was dependent on the c-Src
PDZ ligand (Figs. 2A, B and 3).Mutant Src-A showed weak binding to LNX1. This suggests
that PDZ domain-independent interactions contribute to the
c-Src/LNX1 interaction. Indeed, we observed a weak interac-
tion of SrcNT with LNX1 (data not shown), and SrcCT-A
5136 A. Weiss et al. / FEBS Letters 581 (2007) 5131–5136lacking the SH2, SH3 and SH4 domain of c-Src showed a re-
duced interaction with LNX1 compared to full length Src-A.
However, we cannot exclude indirect interactions mediated
by other proteins.
We also show here that c-Src co-localizes with LNX1 mainly
in regions of cell–cell contacts and in peripheral membrane ruf-
ﬂes when coexpressed in HeLa cells (Fig. 2C). LNX1 acts as
scaﬀold for Numb and interacts with transmembrane proteins
such as ErbB2 [9,11].
We further showed that LNX1 is a target for c-Src-depen-
dent phosphorylation and that phosphorylation sites lie mainly
in the N-terminus (Fig. 4). However, we cannot exclude c-Src-
induced phosphorylation by other tyrosine kinases. Phosphor-
ylation of a PDZ domain protein can regulate the interaction
with its PDZ domain binders [5,12]. Interestingly, coprecipita-
tion of SrcCT-L protein with FLAG-LNX1 was independent
of Src kinase activity. This indicates that Src-dependent
LNX1 phosphorylation is not likely to play a role for the c-
Src/LNX1 interaction, whereas it may regulate the function
of LNX1.
Moreover, we observed Src kinase-dependent mobility shift
of LNX1-bound SrcCT (Fig. 5A). Both, LNX1/SrcCT interac-
tion and mobility shift of LNX1-bound SrcCT increased with
gradual C-terminal deletion of PDZ domains (Fig. 5B). In con-
trast, LNX1-NT lacking all PDZ domains only weakly bound
SrcCT and was not shifted, indicating the requirement for
PDZ1. These ﬁndings are reminiscent of eﬀects shown for
Numb ubiquitination by the same LNX1 mutants [7]. Indeed,
we could demonstrate LNX1-mediated ubiquitination of acti-
vated SrcCT by using MG132 and cycloheximide, which inhi-
bit proteasomal degradation and protein synthesis, thereby
enriching for ubiquitinated SrcCT proteins (Fig. 5C). These
ﬁndings are strengthened by detection of increased SrcCT
ubiquitination in the presence of LNX1 and LNX1DPDZ234
(Fig. 5D). We did not observe similar eﬀects for c-Src. This
may be due to weak kinase activity of c-Src under the experi-
mental conditions used, whereas SrcCT is constitutively acti-
vated. However, the fact that the protein level of
constitutively active SrcY527F is reduced by LNX1 coexpres-
sion (Fig. 5E) suggests that activated Src is degraded by
LNX1-dependent ubiquitination.
Activated Src is a known substrate for the E3 ubiquitin li-
gase c-Cbl leading to degradation of Src [13]. In contrast to
c-Cbl, binding of Src to LNX1 depends on its functional C-ter-
minal PDZ ligand. We suggest that LNX1-associated Src is
ubiquitinated by LNX1 in a kinase-dependent manner and
that the interaction of c-Src and LNX1 could aﬀect the capa-
bility of LNX1 to ubiquitinate other substrates such as Numb
(Fig. 5F).
c-Src is regulated by diﬀerent PDZ domain proteins in diﬀer-
ent way. Here, we show that the PDZ protein LNX1 negatively
regulates activated Src by leading to ubiquitination and degra-
dation. Previously, we demonstrated another mechanism for
regulation of cellular c-Src kinase activity where binding of
c-Src to the AF-6 PDZ domain holds c-Src in a partially activeform and restricts substrate phosphorylation [3], a mechanism
we did not observe for binding to LNX1. These two mecha-
nisms may diﬀer by being irreversible or reversible. The com-
bined loss of these regulatory mechanisms in oncogenic v-Src
and c-Src mutants found in some human tumors, both lacking
the C-terminal sequence, is likely to contribute to the constitu-
tive active nature of these kinases.
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